Credit Assessment_3

We thank the following funding sources:


  • Experimental and Theoretical Studies to Develop Complex Biomaterials, $372,095, National Science Foundation-CAREER. (Conda-Sheridan, PI). 03/01/2020-02/28/2025

  • Title: Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA); Conda-Sheridan group ~$100,000, National Institute of Health—NIAID. 09/01/2021-08/31/2026. Happi, PI.


  • Role of the Clp Protease Systems in the Growth and Pathogenesis of Chlamydia.  $250,000 (Conda-Sheridan group ~$35,000), NIH-NIAID (Ouellette, PI).  10/01/2020-09/31/2021

  • Nebraska Center for Molecular Target Discovery and Development. P20-GM121316, $510,980, NIH-NIGMS. (Lewis, PI; Conda-Sheridan, Co-I). 05/01/2018-04/30/2021

  • Modifying Heterocycles to Treat Gram + and Gram – Bacteria. PRMRP#PR172445, $200,000, Department of Defense. (Conda-Sheridan, PI). 05/01/2018-10/31/2019

  • UNMC Diversity Award. $100,000 (Conda-Sheridan, PI). 06/01/2019-05/31-2021

  • The Evolution of Self-Assembled Organic Materials. PRF# 57434-DNI7, $110,000, American Chemical Society (Conda-Sheridan, PI). 09/01/2017-08/31/2019

  • Nebraska Bankers Association, Equipment grant (To purchase an Isolera Biotage System), $15,000 (Conda-Sheridan, PI). 01/01/2018-04/30/2018

  • Towards an Effective Prostate Cancer Targeting Biomaterial.  1R03EB022141-01. $79,980, NIH-NCI (Conda-Sheridan, PI).  04/01/2016-03/31/2018

  • UNMC Diversity Award. $100,000 (Conda-Sheridan, PI). 06/01/2015-05/31-2017

  • Developing Sugar Amphiphiles, Novel Bioinspired Nanodrugs. DHHS#2018-17, $ 50,000, Nebraska Department of Human Health (Conda-Sheridan, PI). 07/01/2017-06/30/2018